European Markets Rise Amidst Corporate Developments
European markets closed mostly higher in Wednesday's trading (August 5) as investors monitored developments in US-Iran negotiations and corporate earnings reports. The STOXX Europe index edged up about 0.1%, the FTSE 100 rose 0.2%, and the Swiss Market Index gained 0.7%. Meanwhile, Germany's DAX fell 0.1% and France's CAC saw a slight decline. Hopes for the reopening of the Strait of Hormuz helped maintain positive market sentiment.
In the banking sector, Santander shares rose 0.8% after the Federal Reserve approved its plan to acquire Webster Financial. The transaction is targeted for completion on August 20, 2026, and is expected to strengthen Santander's business in the United States.
AstraZeneca surged more than 3% after a senior source denied reports of merger talks with Bristol Myers Squibb. Conversely, Novo Nordisk fell 4.3% despite winning a preliminary ruling in a patent dispute regarding the drug semaglutide. Ryanair rose 0.6% after its passenger numbers for July hit a record 22.2 million, a 7% year-on-year increase.
HSBC was among the stocks weighing on the market, dropping more than 4% after launching a tender offer to repurchase four series of senior debt securities with a maximum value of US$5 billion. These movements indicate that investors remain selective and are focusing more on company-specific developments.
Newsmaker Analysis: European market sentiment remains generally positive as long as Hormuz negotiations show progress and energy prices stay under control. However, the modest gains suggest the market is becoming cautious after indices reached near-record levels. A failure in US-Iran diplomacy could drive oil prices up again and pressure stocks, whereas a formal agreement could potentially extend the rally in the industrial, banking, and transportation sectors. (arl)
Source: Newsmaker.id
